Cipher Pharmaceuticals Inc. (CPHRF)
Market Cap | 225.34M |
Revenue (ttm) | 33.36M |
Net Income (ttm) | 11.55M |
Shares Out | n/a |
EPS (ttm) | 0.46 |
PE Ratio | 19.52 |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 1,300 |
Average Volume | 15,837 |
Open | 8.92 |
Previous Close | 9.13 |
Day's Range | 8.76 - 8.92 |
52-Week Range | 5.62 - 14.60 |
Beta | 1.14 |
RSI | 50.84 |
Earnings Date | Mar 14, 2025 |
About Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwante... [Read more]
Full Company ProfileFinancial Performance
In 2024, Cipher Pharmaceuticals's revenue was $33.36 million, an increase of 57.66% compared to the previous year's $21.16 million. Earnings were $11.55 million, a decrease of -43.36%.
Financial StatementsNews
Cannabis Stock Gainers And Losers From March 27, 2025
GAINERS: CordovaCann (OTC: LVRLF) shares closed up 21.21% at $0.08 Greenlane Hldgs (NASDAQ: GNLN) shares closed up 14.18% at $0.31 Curaleaf Holdings (OTC: CURLF) shares closed up 12.87% at $0.99 Zo...
Cipher Pharmaceuticals Inc (CPHRF) Q4 2024 Earnings Call Highlights: Record Revenue Surge and ...
Cipher Pharmaceuticals Inc (CPHRF) Q4 2024 Earnings Call Highlights: Record Revenue Surge and Strategic Growth Initiatives
Marijuana Stock Movers For March 19, 2025
GAINERS: SOL Glb Inv (OTC: SOLCF) shares closed up 32.00% at $0.12 4Front Ventures (OTC: FFNTF) shares closed up 26.67% at $0.02 Target Group (OTC: CBDY) shares closed up 16.70% at $0.00 Urban-gro ...
Cipher Pharmaceuticals GAAP EPS of $0.13, revenue of $11.82M misses by $0.28M
Cipher Pharmaceuticals Inc. 2024 Q4 - Results - Earnings Call Presentation
The following slide deck was published by Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc. (CPHRF) Q4 2024 Earnings Call Transcript
Cipher Pharmaceuticals GAAP EPS of $0.13 misses by $0.02, revenue of $11.82M misses by $0.43M

Jesse Gamble's Top Picks: Zedcor, Enterprise Group and Cipher Pharmaceuticals
Jesse Gamble, senior VP and portfolio manager at Donville Kent Asset Management, shares his top stock picks; Zedcor, Enterprise Group and Cipher Pharmaceuticals.
Cipher Pharmaceuticals Inc (CPHRF) Q3 2024 Earnings Call Highlights: Revenue Surge and ...
Cipher Pharmaceuticals Inc (CPHRF) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Plans
Q3 2024 Cipher Pharmaceuticals Inc Earnings Call Transcript
Q3 2024 Cipher Pharmaceuticals Inc Earnings Call Transcript
Cipher Pharmaceuticals reports Q3 results
Cipher Pharmaceuticals Reports Third Quarter 2024 Results
(All figures are presented in U.S. Dollars) Successfully closed the acquisition of the U.S. based Natroba™ business on July 26, 2024 Epuris sales volumes grew 29% compared to Q3 2023, continuing growt...
Cannabis Stock Movers For August 29, 2024
GAINERS: Maple Leaf Green World (OTC: MGWFF) shares closed up 88.15% at $0.03 Blueberries Medical (OTC: BBRRF) shares closed up 44.23% at $0.01 Affinor Growers (OTC: RSSFF) shares closed up 15.84% ...
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 26, 2024
GAINERS: Target Group (OTC: CBDY) shares closed up 33.33% at $0.00 CNBX Pharmaceuticals (OTC: CNBX) shares closed up 28.57% at $0.01 Nextleaf Solutions (OTC: OILFF) shares closed up 19.05% at $0.07...
Bullish Monday For Marijuana Stocks - Leafbuyer Techs, Pharmadrug Among Top Gainers
GAINERS: Leafbuyer Techs (OTC: LBUY) shares closed up 100.00% at $0.00 Pharmadrug (OTC: LMLLF) shares closed up 93.18% at $0.02 Elixinol Wellness (OTC: ELLXF) shares closed up 80.77% at $0.00 Globa...

Cipher Pharmaceuticals Inc. (CPHRF) Q1 2024 Earnings Call Transcript
Cipher Pharmaceuticals Inc. (OTCQX:CPHRF) Q1 2024 Earnings Conference Call May 10, 2024 8:30 AM ET Company Participants Craig J. Mull - Interim CEO Bryan Jacobs - CFO Conference Call Participants Andr...

Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
Mississauga, Ontario--(Newsfile Corp. - April 3, 2024) - Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which wil...

Cipher Pharmaceuticals (CPHRF) Q4 2023 Earnings Call Transcript
Cipher Pharmaceuticals (CPHRF) Q4 2023 Earnings Call Transcript

Cipher Pharmaceuticals Inc. (CPHRF) Q3 2023 Earnings Call Transcript
Cipher Pharmaceuticals Inc. (OTCPK:CPHRF) Q3 2023 Earnings Conference Call November 10, 2023 8:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Bryan Jacobs - Chief Financial...

Cipher Pharmaceuticals Inc. (CPHRF) Q2 2023 Earnings Call Transcript
Start Time: 08:30 January 1, 0000 9:00 AM ET Cipher Pharmaceuticals Inc. (OTCPK:CPHRF) Q2 2023 Earnings Conference Call August 11, 2023, 08:30 AM ET Company Participants Craig Mull - Interim CEO Bryan...

Cipher Pharmaceuticals Inc. (CPHRF) Q1 2023 Earnings Call Transcript
Cipher Pharmaceuticals Inc. (OTCPK:CPHRF) Q1 2023 Earnings Conference Call May 12, 2023 8:30 AM ET Corporate Participants Craig Mull - Interim Chief Executive Officer Bryan Jacobs - Chief Financial Of...

Cipher Pharmaceuticals Inc. (CPHRF) Q4 2022 Earnings Call Transcript
Cipher Pharmaceuticals Inc. (OTCPK:CPHRF) Q4 2022 Earnings Conference Call March 17, 2023 8:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Bryan Jacobs - Chief Financial Of...

Cipher Pharmaceuticals Inc. (CPHRF) Q3 2022 Earnings Call Transcript
Cipher Pharmaceuticals Inc. (OTCPK:CPHRF) Q3 2022 Earnings Conference Call November 11, 2022 8:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Bryan Jacobs - Chief Financial...

Cipher Pharmaceuticals Inc. (CPHRF) CEO Craig Mull on Q2 2022 Results - Earnings Call Transcript
Cipher Pharmaceuticals Inc. (OTCPK:CPHRF) Q2 2022 Earnings Conference Call August 12, 2022 8:30 AM ET